What is Organon's common stock, shares authorized (in shares)?

Organon (OGN) reported common stock, shares authorized (in shares) of $500M in Q1 2026.

How has Organon's common stock, shares authorized (in shares) changed year-over-year?

Organon's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $500M to $500M.

What is the long-term trend for Organon's common stock, shares authorized (in shares)?

Over 4 years (2021 to 2025), Organon's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $500M to $500M.

Organon OGN Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

AmgenAMGN

——

The Cooper Companies, Inc.COO

——

AbbVieABBV

——

Envista Holdings CorporationNVST

——

PBH

Prestige Consumer HealthcarePBH

——

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

See full

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

See full

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

See full

Market cap$3.53B-59.4%

Profitability

See full

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

See full

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organon's common stock, shares authorized (in shares)?: Organon (OGN) reported common stock, shares authorized (in shares) of $500M in Q1 2026.
How has Organon's common stock, shares authorized (in shares) changed year-over-year?: Organon's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $500M to $500M.
What is the long-term trend for Organon's common stock, shares authorized (in shares)?: Over 4 years (2021 to 2025), Organon's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $500M to $500M.